Literature DB >> 2039190

Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria.

E Pussard1, J P Lepers, F Clavier, L Raharimalala, J Le Bras, M Frisk-Holmberg, Y Bergqvist, F Verdier.   

Abstract

The efficacy of a loading dose of 20 mg of chloroquine per kg of body weight per os given at intervals during the first day was evaluated in 27 patients in Madagascar with Plasmodium falciparum malaria. The conventional regimen of 25 mg/kg over 3 days (schedule 1) was thus compared with a regimen of 30 mg/kg over 2 days (schedule 2; one dose of 10 mg/kg followed by two doses of 5 mg/kg at 6-h intervals on the first day and two doses of 5 mg/kg at 12-h intervals on the second day) in terms of their clinical and parasitological efficacies, tolerance, and drug concentration-time curves. At 24 h schedule 2 gave higher chloroquine levels in blood, which induced a more rapid decrease in parasitemia. The time required for a 50% decrease in the initial parasitemia was shorter in patients on schedule 2 (14.3 +/- 1.6 h) than it was in patients on schedule 1 (35.5 +/- 5.4 h; P less than 0.01). Moreover, negative blood smears were obtained more rapidly with schedule 2 (50.8 +/- 3.7 h) than with schedule 1 (72 +/- 8.7 h). As predicted by the drug concentration-time curve, no high, potentially toxic peak drug concentration appeared and no adverse effects were observed with the loading dose regimen (schedule 2). These findings support the idea that a loading dose of 20 mg/kg given at intervals during the first 12 h is well tolerated and can be used to obtain a more rapid decrease in parasitemia and to shorten the treatment time of uncomplicated chloroquine-susceptible falciparum malaria in the field.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039190      PMCID: PMC245023          DOI: 10.1128/AAC.35.3.406

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Sudden increase in number of isolates of Plasmodium falciparum resistant to chloroquine in Madagascar.

Authors:  J P Lepers; P Deloron; J C Mouden; J Le Bras; P Coulanges
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jul-Aug       Impact factor: 2.184

2.  Determination of chloroquine and its metabolites in urine: a field method based on ion-pair extraction.

Authors:  Y Bergqvist; C Hed; L Funding; A Suther
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Blood levels and in vitro activity of desethylchloroquine against Plasmodium falciparum.

Authors:  F Verdier; J Le Bras; F Clavier; I Hatin
Journal:  Lancet       Date:  1984-05-26       Impact factor: 79.321

4.  Parasitologic and clinical efficacy of 25 and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children.

Authors:  J D Sexton; P Deloron; L Bugilimfura; A Ntilivamunda; M Neill
Journal:  Am J Trop Med Hyg       Date:  1988-03       Impact factor: 2.345

5.  Reappearance of falciparum malaria in central highland plateaux of Madagascar.

Authors:  J P Lepers; P Deloron; D Fontenille; P Coulanges
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

6.  The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.

Authors:  M Frisk-Holmberg; Y Bergqvist; E Termond; B Domeij-Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Parenteral chloroquine for treating falciparum malaria.

Authors:  N J White; G Watt; Y Bergqvist; E K Njelesani
Journal:  J Infect Dis       Date:  1987-02       Impact factor: 5.226

8.  Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria.

Authors:  O Walker; A H Dawodu; A A Adeyokunnu; L A Salako; G Alvan
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

9.  Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography.

Authors:  E Pussard; F Verdier; M C Blayo
Journal:  J Chromatogr       Date:  1986-01-10

10.  Kinetics of the uptake and elimination of chloroquine in children with malaria.

Authors:  S A Adelusi; A H Dawodu; L A Salako
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

View more
  8 in total

Review 1.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

Review 2.  Antimalarial pharmacokinetics and treatment regimens.

Authors:  N J White
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.

Authors:  Johan Ursing; Poul-Erik Kofoed; Amabelia Rodrigues; Daniel Blessborn; Rikke Thoft-Nielsen; Anders Björkman; Lars Rombo
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

5.  Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau.

Authors:  Johan Ursing; Poul-Erik Kofoed; Amabelia Rodrigues; Yngve Bergqvist; Lars Rombo
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

6.  Validation of a chloroquine-induced cell death mechanism for clinical use against malaria.

Authors:  J-H Ch'ng; Y-Q Lee; S Y Gun; W-N Chia; Z-W Chang; L-K Wong; K T Batty; B Russell; F Nosten; L Renia; K S-W Tan
Journal:  Cell Death Dis       Date:  2014-06-26       Impact factor: 8.469

Review 7.  Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.

Authors:  Cornelis Smit; Mariska Y M Peeters; John N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

8.  Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention.

Authors:  Mohammad Tarek; Andrea Savarino
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-12       Impact factor: 2.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.